Last reviewed · How we verify
thiamazole
thiamazole is a drug. It is currently in unknown development for Hyperthyroidism.
Thiamazole, also known as methimazole, is a medication used to treat hyperthyroidism, including conditions such as Graves' disease and toxic multinodular goiter. It works by inhibiting thyroid peroxidase, a key enzyme in the production of thyroid hormones.
At a glance
| Generic name | thiamazole |
|---|---|
| Target | Lactoperoxidase, Taste receptor type 2 member 38, Thyroid peroxidase |
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
- Hyperthyroidism
Common side effects
Key clinical trials
- The Observation Study of Graves' Disease Cohort (N/A)
- A Single Arm Pilot Study to Evaluate the Safety and Feasibility of Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma (EARLY/Phase 1)
- A Retrospective and Prospective Observational Study of Hyperthyroidism in Children (N/A)
- Mechanism of NK Cell Disfunction in Graves' Disease (N/A)
- Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis: Review on the Pathway of Insulin Resistance, Lipid, Inflammation, and Endothelial Dysfunction to Puls (Phase 3)
- Comparison of the Effect of Bromocriptine and Pentoxifylline in Mild to Moderate Autoimmune Ophthalmopathy. A Randomized, Controlled, Single Blind, Clinical Trial. (NA)
- Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) (Phase 4)
- Targeting Transsulfuration Via Suppression of Thyroid Hormone Signaling in Progressive Glioblastoma: Phase 2 and Pharmacodynamic Trial of Methimazole in Patients With Progressive Glioblastoma (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- thiamazole CI brief — competitive landscape report
- thiamazole updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about thiamazole
What is thiamazole?
What is thiamazole used for?
What development phase is thiamazole in?
What does thiamazole target?
Related
- Target: All drugs targeting Lactoperoxidase, Taste receptor type 2 member 38, Thyroid peroxidase
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
- Indication: Drugs for Hyperthyroidism
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing